Nicotinic Acid 250mg

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

nicotinic acid, Quantity: 250 mg

Disponible desde:

Alphapharm Pty Ltd

formulario farmacéutico:

Tablet, uncoated

Composición:

Excipient Ingredients: lactose monohydrate; magnesium stearate; maize starch; povidone; purified talc

Vía de administración:

Oral

Unidades en paquete:

200 tablets, 100 tablets

clase:

Medicine Registered

tipo de receta:

(S3) Pharmacist Only Medicine

indicaciones terapéuticas:

Nicotinic acid is an essential dietary constituent, the lack of which leads to the clinical condition known as pellagra, which is characterised by loss of appetite, lethargy, weakness, diarrhoea, dermatitis and mental changes. An erythematous eruption resembling sunburn first appears on the back of the hands. Other areas exposed to light are later involved and eventually the lesions may be more widespread. The cutaneous manifestations are characteristically symmetrical and may darken, desquamate and scar. Nicotinic acid has been approved for the treatment of hypercholesterolaemia and hypertriglyceridaemia. It should be used as adjunctive therapy in addition to diet and other measures. Nicotinic acid can also be used to treat Frederickson-Lees Levy hyperlipoproteinaemia type II, IIB, III, IV and V.

Resumen del producto:

Visual Identification: White, bevelled edge tablet with breakline on one side; Container Type: Bottle; Container Material: Glass; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Estado de Autorización:

Registered

Fecha de autorización:

1991-10-21